combined CXCL11-loaded oncolytic virus (oAds-CXCL11) with CAR-T cell therapy and found an increase in T-cell and NK infiltration, as well as a significant decrease in M2-type macrophages in mouse GBM model. Here, CXCL11 is linked to glioblastoma.